Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)
Leader Capital Markets analyst Sabina Levi maintained a Buy rating on Teva (TEVA – Research Report) today and set a price target of ILA9,300.00. The company's shares closed yesterday at ILA6,281.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Levi is an analyst with an average return of -5.5% and a 0.00% success rate.
The analyst consensus on Teva is currently a Hold rating.
Based on Teva's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of ILA3.89 billion and a net profit of ILA214 million. In comparison, last year the company earned a revenue of ILA3.82 billion and had a GAAP net loss of ILA139 million
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Returns On Capital Signal Tricky Times Ahead For Homeritz Corporation Berhad (KLSE:HOMERIZ)
What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. In light of that, when we looked at Homeritz Corporation Berhad (KLSE:HOMERIZ) and its ROCE trend, we weren't exactly thrilled. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. Analysts use this formula to calculate it for Homeritz Corporation Berhad: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.12 = RM36m ÷ (RM331m - RM29m) (Based on the trailing twelve months to February 2025). Therefore, Homeritz Corporation Berhad has an ROCE of 12%. In absolute terms, that's a satisfactory return, but compared to the Consumer Durables industry average of 4.4% it's much better. Check out our latest analysis for Homeritz Corporation Berhad Above you can see how the current ROCE for Homeritz Corporation Berhad compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free analyst report for Homeritz Corporation Berhad . In terms of Homeritz Corporation Berhad's historical ROCE movements, the trend isn't fantastic. Around five years ago the returns on capital were 17%, but since then they've fallen to 12%. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run. In summary, despite lower returns in the short term, we're encouraged to see that Homeritz Corporation Berhad is reinvesting for growth and has higher sales as a result. And the stock has followed suit returning a meaningful 56% to shareholders over the last five years. So should these growth trends continue, we'd be optimistic on the stock going forward. If you want to continue researching Homeritz Corporation Berhad, you might be interested to know about the 2 warning signs that our analysis has discovered. While Homeritz Corporation Berhad isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
7 hours ago
- Yahoo
AST SpaceMobile Stock (ASTS) Rallies Alongside Surging Demand for Satellite Internet
AST SpaceMobile Inc. (ASTS) is helping shape the future of global internet connectivity through its ambitious satellite-based technology. With the potential to expand reliable internet access to remote and underserved regions, support growing government contracts, and meet the rising demands of data connectivity across industries, satellite internet is emerging as a transformative force in communications (and the stock market). Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The market for satellite internet is projected to grow rapidly, with analysts estimating it could reach $24.6 billion by 2030, representing a compound annual growth rate of 30%. ASTS stock is following this trend, recording a surging 14% gain over the past week and a 47% gain year-to-date. What sets ASTS apart is its goal to connect standard, unmodified smartphones directly to satellites—unlike competitors such as SpaceX's Starlink, which requires proprietary equipment, or Amazon's (AMZN) Project Kuiper, which focuses on fixed installations. If successful, ASTS could dramatically improve connectivity for billions of people, especially in regions where only about 34% of the Earth currently has cellular coverage. The company has made notable progress toward key technical and operational milestones and holds sufficient capital to support its near-term plans. While ASTS remains a speculative investment at this stage, I believe its long-term potential is significant and view the upside as compelling. AST SpaceMobile's direct-to-smartphone approach requires no special hardware or apps, which could be a game-changing development. This technology could unlock massive markets, particularly in developing countries where traditional internet infrastructure is limited. The company plans to launch five satellites over the next six to nine months, starting with its first Block 2 BlueBird satellite in July 2025. If these launches proceed smoothly, ASTS could begin generating meaningful revenue from both government contracts and commercial partnerships in short order. Manufacturing is another potential key advantage. The company aims to build the capability to produce six satellites per month by late 2025, which would enable rapid network expansion once the technology is proven in orbit. AST SpaceMobile is still in its early stages, burning through cash as it builds its satellite network. The company reported revenue of just $718,000 for Q1 2025, falling well short of the $4 million that analysts expected. The company also reported a net loss of $45.7 million, which is significantly wider than the loss it incurred in the previous year. However, the spacefarer has significantly strengthened its financial position, raising over $500 million in recent funding rounds. With $874 million in cash on hand and manageable debt levels, ASTS has enough runway to execute its plans for at least the next 12 months. Management is projecting dramatic revenue growth with a projected second-half 2025 revenue of $50 million to $75 million. Of course, these projections depend entirely on the successful launch of its satellites and the activation of commercial services, highlighting the crucial role execution plays in the company's near-term success. AST SpaceMobile is ambitiously pushing the boundaries of satellite communications, but that journey (like so many novel technologies) comes with inherent risks that investors should carefully weigh. As AST seeks to fill the gaps of global connectivity, its success hinges on flawless execution. Any hiccup in launching its satellites or deploying its technology could trigger a swift adverse reaction in the share price. The company also faces competition from established titans like SpaceX and Amazon's Blue Origin. For AST to carve out a niche, swift market penetration is crucial to avoid being eclipsed by these well-resourced rivals. Further, establishing a global satellite network involves securing approvals from numerous countries. The layers of bureaucracy, red tape, and regulatory compliance that the company must navigate could slow its expansion timeline. Finally, the path to building a satellite network comes with a hefty price tag. The company is likely to need to raise additional capital in the future, which could result in the dilution of existing shares. The company has recently won several government contracts, including a $43 million deal with the U.S. Space Development Agency, which provides revenue visibility and validates the technology's potential. Meanwhile, members of the Blue Origin management team visited the AST headquarters in Texas recently, sparking speculation of a potential partnership with Amazon. While nothing has been confirmed, such a partnership could provide ASTS with additional resources and credibility. The stock has responded positively to the news (and rumors), with shares up over 23% in the past month, bullishly trading above major moving averages (20-day, 50-day, and 200-day). TipRanks currently rates AST SpaceMobile as a Strong Buy, based on the consensus of five analyst recommendations. The stock carries an average price target of $38.60, suggesting a potential upside of 24% over the next twelve months. AST SpaceMobile has caught Wall Street's attention. In a recent report by Scotiabank's Andres Coello, ASTS has been given a Buy rating, along with a price target of $45.40. Coello noted speculation surrounding potential interest from Amazon's Jeff Bezos, especially after a recent Instagram post hinted at possible collaborations with Blue Origin. Meanwhile, Cantor Fitzgerald's Colin Canfield has reiterated an Overweight rating with a $30 price target, highlighting the company is nearing its full-year revenue guidance for the first time, backed by constructive updates on satellite deployment and defense equipment bookings. He notes optimism surrounding the company's strategic moves, despite an anticipated rise in deployment costs. AST SpaceMobile is at the forefront of next-generation global connectivity. The market opportunity is significant, and the underlying technology holds considerable promise. That said, the company faces a range of challenges, including technical hurdles, funding requirements, regulatory complexities, and intense competition. This investment may not be appropriate for all investors. Still, for those with a higher risk tolerance, ASTS offers exposure to potentially game-changing innovation in the rapidly expanding satellite internet sector. With the satellite internet revolution approaching, I remain optimistic about AST SpaceMobile's potential to play a leading role in shaping its future. Disclaimer & DisclosureReport an Issue Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Upturn
8 hours ago
- Business Upturn
Iovance Biotherapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before July 14, 2025 to Discuss Your Rights
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Iovance investors who were adversely affected by alleged securities fraud between May 9, 2024 and May 8, 2025. Follow the link below to get more information and be contacted by a member of our team: Iovance Lawsuit Submission Form IOVA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, throughout the class period, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Iovance's growth potential; notably, that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers. On July 25, 2024, Iovance announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on 1) 'the iCTC completed annual scheduled maintenance in December' and 'capacity was reduced by more than half for about 1 month,' 2) '[l]ower Proleukin sales' than the company expected, and 3) 'the variable pace at which ATCs began treatment patients.' Following this news, the price of Iovance's common stock declined dramatically. From a closing market price of $3.17 per share on May 8, 2025, Iovance's stock price fell to $1.75 per share on May 9, 2025, a decline of about 44.795% in the span of just a single day. WHAT'S NEXT? If you suffered a loss in Iovance during the relevant time frame, you have until July 14, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004 [email protected] Tel: (212) 363-7500Fax: (212) 363-7171
